Bibliography
- MAY JM, D'AQUISTO F, MADGE LA et al: Selective inhibition of NF-x13 activation by a peptide that blocks the interaction of NEMO with the IKB kinase complex. Science (2000) 289:1550–1554.
- JIMI E, AOKI K, SAITO H et al: Selective inhibition of NF-KB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. (2004) 10:617–624.
- PIKARSKY E, PORAT RM, STEIN I et al: NF-KB functions as a tumour promoter in inflammation-associated cancer. Nature (2004) 431:461–466.
- MABUCHI S, OHMICHI M, NISHIO Y et al.: Inhibition of NFKB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. Biol. Chem. (2004) 279:23477–23485.
- RUNDALL BK, DENLINGER CE, JONES DR: Combined histone deacetylase and NF-KB inhibition sensitized non-small cell lung cancer to cell death. Surgery (2004) 136:416–425.